These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4577820)

  • 21. Adverse reactions during treatment of Parkinson's disease with levodopa.
    Martin WE
    JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258
    [No Abstract]   [Full Text] [Related]  

  • 22. Levodopa therapy effects on natural history of Parkinsonism.
    Stern PH; McDowell F; Miller JM; Robinson MB
    Arch Neurol; 1972 Dec; 27(6):481-5. PubMed ID: 4628440
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of orthostatic dysregulation. Comparative studies on anti-hypotensive sympathomimetics with a tilt-table test].
    Lossnitzer K; Gäb J
    Fortschr Med; 1980 Aug; 98(29):(1133-6). PubMed ID: 6108908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A second report on Levodopa.
    Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 26. Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome.
    Langrall HM; Joseph C
    Clin Pharmacol Ther; 1971; 12(2):323-31. PubMed ID: 4930865
    [No Abstract]   [Full Text] [Related]  

  • 27. Levodopa and orphenadrine hydrochloride in Parkinsonism.
    Whyte RK; Hunter KR; Laurence DR; Stern GM; Armitage P
    Eur J Clin Pharmacol; 1971 Dec; 4(1):18-21. PubMed ID: 4948768
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the effectiveness of Thomasin (etilefrin) in hypotensive and/or orthostatic circulatory disorders in comparison with pholedrine and placebo (double-blind study)].
    Gruber G
    Z Arztl Fortbild (Jena); 1982 Feb; 76(4):149-53. PubMed ID: 6125062
    [No Abstract]   [Full Text] [Related]  

  • 29. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific therapy in Parkinson's disease.
    Med J Aust; 1970 Oct; 2(14):612-3. PubMed ID: 5477804
    [No Abstract]   [Full Text] [Related]  

  • 31. Levodopa: alterations in behavior.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):383-96. PubMed ID: 4930867
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of fusaric acid in Parkinson's disease.
    Herskovits E; Figueroa Gacitua E
    Medicina (B Aires); 1973; 33(1):51-8. PubMed ID: 4573120
    [No Abstract]   [Full Text] [Related]  

  • 33. [Orthostatic hypotension as autonomic side-effect of neuroleptic therapy and attempts at its medicamentous compensation].
    Müller H; Battegay R; Gehring A
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(2):365-87. PubMed ID: 5365120
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of midodrine on chlorpromazine-induced orthostatic hypotension in rabbits: comparison with amezinium, etilefrine and droxidopa.
    Kurihara J; Takata Y; Suzuki S; Okubo Y; Kato H
    Biol Pharm Bull; 2000 Dec; 23(12):1445-9. PubMed ID: 11145175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy of Parkinson's diseases].
    Lhermitte F; Degos CF
    Acquis Med Recent; 1972; ():73-80. PubMed ID: 4667798
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of patients with postencephalitic Parkinsonism to levodopa.
    Duvoisin RC; Lobo-Antunes J; Yahr MD
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):487-95. PubMed ID: 5049808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood pressure effects of apomorphine and domperidone in parkinsonism.
    Pollak P; Mallaret M; Gaio JM; Hommel M; Perret J
    Adv Neurol; 1987; 45():263-6. PubMed ID: 3548261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.